Director Corporate Drug Safety
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Hellerup
…responsibility for all drug safety related activities for early as well as late stage development projects.
As the new Director of CDS you will function as part of our experienced drug safety team. Additionally, CDS operates with a semi-outsourcing model where case management and reporting has been outsourced to a safety vendor, whereas safety surveillance is kept within the company.
As the new Director your main task will be (in collaboration with the Sr. Director, CDS) to hold the responsibility for all drug safety related activities for early as well as late stage development projects.
Personal and professional qualifications:
Y-mAbs offers:
As the new Director of CDS you will function as part of our experienced drug safety team. Additionally, CDS operates with a semi-outsourcing model where case management and reporting has been outsourced to a safety vendor, whereas safety surveillance is kept within the company.
As the new Director your main task will be (in collaboration with the Sr. Director, CDS) to hold the responsibility for all drug safety related activities for early as well as late stage development projects.
Personal and professional qualifications:
- 3+ years’ experience within corporate drug safety
- Certified MD, nurse, pharmacist or equivalent
- Prior experience with case management
- Prior experience with safety surveillance
- Prior experience responding to Health Authorities on safety related issues
- Prior experience working with safety CRO’s
- Experience with and in-depth knowledge of safety reporting and requirements from a global perspective, covering both EU and US is an advantage
- We expect you to have an entrepreneurial mindset
- Demonstrates initiative and capacity to work under pressure
- As a team player, you can work with ambitious timelines in our slim organization with a cross-functional team
- You are result-oriented and committed to contributing to the overall success of Y-mAbs
- Ability to communicate complex clinical issues and analysis orally and in writing
- Capability to synthesize and critically analyze data from multiple sources
- The company language is English, so your communication in both written and spoken English is fluent
Y-mAbs offers:
- An exciting work environment where challenging assignments will come your way
- Great office location at DTU Science Park including canteen and easy parking
- Competitive salary package
Information og data
Denne ledige stilling har jobtypen "Kemiker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Hellerup.
Jobbet er oprettet på vores service den 13.11.2019, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Kemiker
- Hellerup
Lignende jobs
-
Polymerkemiker med sans for kunderådgivning
Lokation: Denmark, FORCE Technology - BrøndbyVil du arbejde med rådgivning, test og analyse af polymermaterialer? Og vil du være med til at sikre grøn omstilling for vores kunder? Så bliv mater..Få mere info- Kemiker
- Brøndby
-
Kemiker med interesse for farmaceutiske analyser s...
Firmabeskrivelse Har du lyst til at springe ud i nye opgaver og blive en del af et ambitiøst team? Så læs mere her.Eurofins BioPharma Product Testing Denmark A/S er et verdensførende globalt .Få mere info- Kemiker
- Glostrup
Statistik over udbudte jobs som kemikere i Hellerup
Herunder ser du udviklingen i udbudte kemiker i Hellerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal kemikere.
Se flere statistikker her:
Statistik over udbudte kemikere i Hellerup over tid
| Dato | Alle jobs som kemikere |
|---|---|
| 9. november 2024 | 0 |
| 8. november 2024 | 0 |
| 7. november 2024 | 0 |
| 6. november 2024 | 0 |
| 5. november 2024 | 0 |
| 4. november 2024 | 0 |
| 3. november 2024 | 0 |
| 2. november 2024 | 0 |
| 1. november 2024 | 0 |
| 31. oktober 2024 | 0 |
| 30. oktober 2024 | 0 |
| 29. oktober 2024 | 0 |
| 28. oktober 2024 | 0 |
| 27. oktober 2024 | 0 |
| 26. oktober 2024 | 0 |
| 25. oktober 2024 | 0 |
| 24. oktober 2024 | 0 |
| 23. oktober 2024 | 0 |
| 22. oktober 2024 | 0 |
| 21. oktober 2024 | 0 |
| 20. oktober 2024 | 0 |
| 19. oktober 2024 | 0 |
| 18. oktober 2024 | 0 |
| 17. oktober 2024 | 0 |
| 16. oktober 2024 | 0 |
| 15. oktober 2024 | 0 |
| 14. oktober 2024 | 0 |
| 13. oktober 2024 | 0 |
| 12. oktober 2024 | 0 |
| 11. oktober 2024 | 0 |
| 10. oktober 2024 | 0 |